PNC Financial Services Group’s SOPHiA GENETICS SOPH Stock Holding History
Bought
Maintained
Sold
Other funds holding SOPH
GIM
ACM
BPC
SCM
RA
AWA
KCM
EIM
PNC Financial Services Group's SOPH Position: Q1 2026 in Review
PNC Financial Services Group sold out of SOPHiA GENETICS (SOPH) in Q1 2026, closing a stake of 370 shares — an estimated $1.73K sold.
PNC Financial Services Group first reported a position in SOPH in Q4 2025 and held it in 1 quarter. The position peaked at $1.73K in Q4 2025. 49 funds tracked by Wall St. Rank hold SOPH as of Q1 2026.
- PNC Financial Services Group reported no remaining SOPHiA GENETICS position as of Q1 2026 after selling out during the quarter.
- PNC Financial Services Group sold 370 SOPHiA GENETICS shares in Q1 2026, an estimated $1.73K.
- PNC Financial Services Group first reported a position in SOPHiA GENETICS in Q4 2025 and held it in 1 quarter.
- PNC Financial Services Group's SOPHiA GENETICS position peaked at $1.73K in Q4 2025.
- 49 funds tracked by Wall St. Rank held SOPHiA GENETICS as of Q1 2026.
Based on PNC Financial Services Group's 13F filing for Q1 2026, filed 8 May 2026.